Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc. (IDYA) Stock Overview

Explore IDEAYA Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

IDYA●NASDAQ
HealthcareBiotechnology
$35.59
$0.57(1.58%)
U.S. Market opens in 13h 46m

IDEAYA Biosciences, Inc. (IDYA)

Meyka AI Score

Z

Key Financials

Market Cap3.4B
P/E Ratio-22.70
EPS (TTM)$-1.60
ROE-0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$34.82
3 Months$40.92
1 Year Target$37.59

IDYA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of IDEAYA Biosciences, Inc. (NASDAQ: IDYA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, IDEAYA Biosciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IDYA on the NASDAQ shows an RSI of 50.73, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $37.59 for the NASDAQ listing.

Key metrics behind IDEAYA Biosciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -22.70 and a market capitalization of 3.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of IDYA on the NASDAQ.

Price Performance (NASDAQ: IDYA)

1-Day Change
-1.58%
5-Day Change
-3.55%
1-Month Change
-2.63%
3-Month Change
26.88%
6-Month Change
7.88%
Year-to-Date (YTD) Change
2.95%
1-Year Change
43.28%
3-Year Change
59.17%
5-Year Change
51.51%
All-Time (Max) Change
218.05%

Contact Information

https://www.ideayabio.com
650 443 6209
7000 Shoreline Court, South San Francisco, CA, 94080

Company Facts

1,450 Employees
IPO DateMay 23, 2019
CountryUS
Actively Trading

Frequently Asked Questions